RALICA HOUSTON: Open Payments
NPI 1699214577 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 14 payments from 5 companies in 2025. Trend: 2023 $200 · 2024 $320 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| PFIZER INC. | 4 | $66 |
| Amgen Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $43 |
| Abbott Laboratories | 1 | $25 |
Products named: LEQVIO, ELIQUIS, KRYSTEXXA, VRAYLAR, FREESTYLE LIBRE 3, REPATHA.
Industry payments across TX — which companies pay providers there.
